Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of a Twenty-Four-Week Pomegranate Seed Oil Supplementation in Palliative Care Patients With Advanced Dementia: A Double Blind, Randomized Controlled Clinical Study

NCT07432763 is registered in ClinicalTrials.gov with Panhellenic Federation of Alzheimer's Disease and Related Disorders as lead sponsor.

NCT NCT07432763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of a Twenty-Four-Week Pomegranate Seed Oil Supplementation in Palliative Care Patients With Advanced Dementia: A Double Blind, Randomized Controlled Clinical Study
Lead sponsor
Panhellenic Federation of Alzheimer's Disease and Related Disorders
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2024
Completion date
October 31, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antipsychotics discontinuation, antipsychotics tapering, urinary tract infection, recurrent, urinary tract infections (utis)